Report coverage - PowerPoint PPT Presentation



DPI Research Published a New Report on Thailand MICE Tourism Market

DPI Research Published a New Report on Thailand MICE Tourism Market

DPI Research report titled "Thailand MICE Industry & Forecast to 2022" provides detailed information on the Thailand MICE Industry. This report analyzes market data and provides a better understanding of MICE travelers flows and revenue to Thailand. Market outlook in value terms for the forecasted period for Thailand MICE Industry has been detailed in the report. This report also entails a detailed description of growth drivers and challenges of the Thailand MICE Industry. Thailand MICE Industry have been analyzed from 4 viewpoints: 1. Thailand MICE Travelers Inflow, Revenue & Forecast - Regional Analysis (2012 - 2022) 2. Thailand MICE Travelers Inflow, Revenue & Forecast - Country Wise Analysis (2012 - 2022) 3. Thailand MICE Travelers Inflow, Revenue & Forecast - Industry Analysis (2012 - 2022) 4. Thailand MICE Industry – Growth Drivers & Challenges Thailand MICE Industry & Forecast to 2022 - By Industry Analysis 1. Meetings 2. Incentives 3. Conventions 4. Exhibitions Thailand MICE Industry & Forecast to 2022 – By Regional Analysis 1. East Asia 2. Europe 3. The Americas 4. South Asia 5. Oceania 6. Middle East 7. Africa Thailand MICE Industry & Forecast to 2022 - Countries Wise Analysis 1. Cambodia 2. Indonesia 3. Loas 4. Malaysia 5. Myanmar 6. Philippines 7. Singapore 8. Vietnam 9. China 10. Hong Kong 11. Japan 12. Korea 13. Taiwan 14. France 15. Germany 16. Russia 17. Italy 18. United Kingdom 19. USA 20. Canada 21. Brazil 22. Bangladesh 23. India 24. Pakistan 25. Sri Lanka 26. Australia 27. New Zealand 28. Isreal 29. UAE 30. South Africa 31. Other Countries Data Sources The information contained in this report is based on both primary and secondary sources. Primary Sources: Questionnaires, surveys, telephonic interviews with industry experts and observations Secondary Sources: Secondary data analysis and review involves collecting and analysing a vast array of information. DPI Research seeks information from different sources such as published articles, company websites, magazine articles, associations, trade journals, annual reports, newspapers, books, Government official websites and other paid database sources. Contact US Maria Rai Sales Manager sales@dpiresearch.com

197 views • 6 slides


United States Influenza Vaccine Market,Production, Distribution and Forecast to 2022

United States Influenza Vaccine Market,Production, Distribution and Forecast to 2022

United States Influenza Vaccine Market is expected to reach more than US$ 2.5 Billion by the year end of 2022. Market growth can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against influenza vaccine and introduction of quadrivalent influenza vaccine. The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It provides essential insights into United States influenza vaccine market and forecast. It covers vaccination pattern, doses distribution, production and offers a clear view of the regulatory landscape. Additionally, the report includes insight of clinical trials, pipeline and promising vaccines in United States influenza vaccine market. Key trends in terms of M&A, collaborations and licensing agreements are analyzed with details. The report concludes with the profiles of major players in the influenza vaccine market such as Sanofi Pasteur, GSK, Seqirus, AstraZenecca and Protein Sciences Corporation. The major market players are evaluated on various parameters such as company overview, product outlook and sales analysis of influenza vaccine market from 2011 to 2022. Other emerging players such as Novavax, Daiichi–Sankyo, Mitsubishi Tanabe Pharma, BiondVax Pharmaceuticals Ltd, and VaxInnate are making novel technology based influenza vaccine which is likely to affect the market share during the forecast period. The report also entails major drivers and barriers of influenza vaccine market. Major and Promising Vaccine covered in the report are as follows: 1. Fluzone High–Dose 2. Fluzone Quadrivalent 3. Intradermal (ID) Trivalent 4. Vaxigrip 5. Fluarix Quadrivalent 6. Flulaval Quadrivalent 7. Fluenz Tetra 8. FluMist Quadrivalent 9. Flublok 10. VN–100 11. M–001 12. VAX–2012Q 13. TAK – 850 14. Flucelvax Quadrivalent 15. Afluria Quadrivalent 16. Agrippal 17. Fluad 18. Fluvirin 19. Fluvax Key Companies Covered in the Report are as follows 1. Sanofi Pasteur 2. GlaxoSmithKline(GSK) 3. Seqirus 4. AstraZenecca 5. Protein Sciences Corporation 6. Novavax 7. Daiichi–Sankyo 8. Mitsubishi Tanabe Pharma 9. BiondVax Pharmaceuticals Ltd 10. VaxInnate Contact Info: Name: Maria Rai,Sales Manager Email: sales@dpiresearch.com Organization: DPI Research Phone: 91 728-994-9987

169 views • 6 slides


DPI Research Published a New Report on United States Influenza Vaccine Market

DPI Research Published a New Report on United States Influenza Vaccine Market

United States Influenza Vaccine Market is expected to reach more than US$ 2.5 Billion by the year end of 2022.<br><br>Market growth can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against influenza vaccine and introduction of quadrivalent influenza vaccine. <br><br>The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It provides essential insights into United States influenza vaccine market and forecast. It covers vaccination pattern, doses distribution, production and offers a clear view of the regulatory landscape. Additionally, the report includes insight of clinical trials, pipeline and promising vaccines in United States influenza vaccine market. Key trends in terms of M&A, collaborations and licensing agreements are analyzed with details. <br><br>The report concludes with the profiles of major players in the influenza vaccine market such as Sanofi Pasteur, GSK, Seqirus, AstraZenecca and Protein Sciences Corporation. The major market players are evaluated on various parameters such as company overview, product outlook and sales analysis of influenza vaccine market from 2011 to 2022. Other emerging players such as Novavax, Daiichi–Sankyo, Mitsubishi Tanabe Pharma, BiondVax Pharmaceuticals Ltd, and VaxInnate are making novel technology based influenza vaccine which is likely to affect the market share during the forecast period. The report also entails major drivers and barriers of influenza vaccine market. <br><br><br>Major and Promising Vaccine covered in the report are as follows:<br><br><br>1. Fluzone High–Dose<br>2. Fluzone Quadrivalent<br>3. Intradermal (ID) Trivalent <br>4. Vaxigrip <br>5. Fluarix Quadrivalent <br>6. Flulaval Quadrivalent<br>7. Fluenz Tetra <br>8. FluMist Quadrivalent <br>9. Flublok<br>10. VN–100<br>11. M–001 <br>12. VAX–2012Q <br>13. TAK – 850 <br>14. Flucelvax Quadrivalent <br>15. Afluria Quadrivalent<br>16. Agrippal<br>17. Fluad <br>18. Fluvirin<br>19. Fluvax <br><br>Key Companies Covered in the Report are as follows<br><br><br>1. Sanofi Pasteur <br>2. GlaxoSmithKline(GSK) <br>3. Seqirus<br>4. AstraZenecca <br>5. Protein Sciences Corporation<br>6. Novavax <br>7. Daiichi–Sankyo <br>8. Mitsubishi Tanabe Pharma <br>9. BiondVax Pharmaceuticals Ltd<br>10. VaxInnate<br><br>Contact Info:<br>Name: Maria Rai,Sales Manager<br>Email: sales@dpiresearch.com<br>Organization: DPI Research<br>Phone: 91 728-994-9987<br>

212 views • 6 slides


DPI Research Published a New Report on High Intensity Focused Ultrasound(HIFU) Market

DPI Research Published a New Report on High Intensity Focused Ultrasound(HIFU) Market

High–Intensity Focused Ultrasound (HIFU) is a highly precise medical procedure that applies high–intensity focused ultrasound energy to locally heat and destroy diseased or damaged tissue through ablation.HIFU is one modality of therapeutic ultrasound, involving minimally invasive or non–invasive methods to direct acoustic energy into the body.In HIFU therapy, ultrasound beams are focused on diseased tissue, and due to the significant energy deposition at the focus, temperature within the tissue can rise to levels from 65° to 85°C, destroying the diseased tissue by coagulation necrosis. Recent advances in HIFU, which was developed in the 1940s as a viable thermal tissue ablation approach, have increased its popularity. In clinics, HIFU has been applied to treat a variety of solid malignant tumors in a well–defined volume, including the pancreas, liver, prostate, breast, uterine fibroids, and soft–tissue sarcomas. In comparison to conventional tumor/cancer treatment modalities, such as open surgery, radio– and chemo–therapy, HIFU has the advantages of non–invasion, non–ionization, and fewer complications after treatment. More than 115, 000 cases have been treated throughout the world with great success till 2015. High prevalence of cardiovascular diseases and cancer cases, rapidly growing aging population, rising number of new product launches, growing number of clinical studies regarding the applications of HIFU, and increasing focus of key players on the development of technologically advanced systems are the key factors driving the market growth. Moreover, emerging applications such as gynecology & obstetrics, neurosurgery, urinary disorders imaging, and removal of excess subcutaneous fatty tissue using high–energy sound waves would further propel the growth of the high–intensity focused ultrasound market in the coming six years. However, the stringent government regulations for the approval of HIFU system, rising price pressure faced by market players and unfavorable of reimbursement scenario are the key factors restraining the growth of this market. The Research report presents a comprehensive assessment of the HIFU manufacturers, research sites, pre–clinical research sites, clinical research sites, commercial treatment sites, treatment by indication.The report also brings together major distribution agreement, collaboration deals and partnership deals information in the HIFU market. Furthermore, each company have been profiled on the basis of various attributes such as company overview, HIFU products, latest developments, growth strategies and financial revenue. The following 10 companies of the High Intensity Focused Ultrasound market are detailed with: Company Overview HIFU Products Companies HIFU Revenue Latest Development in High Intensity Focus Ultrasound (HIFU) Market High Intensity Focused Ultrasound(HIFU) – 10 Companies covered 1) EDAP TMS 2) Sonacare Medical 3) Haifu Medical 4) Shanghai A&S Co., LTD 5) Mianyang Sonic Electronic Ltd. 6) Insightec 7) Theraclion 8) Alpinion Medical Systems 9) FUS Instruments 10) Image Guided Therapy Contact Info: Name: Maria Rai,Sales Manager Email: sales@dpiresearch.com Organization: DPI Research Phone: 91 728-994-9987

163 views • 5 slides


View Report coverage PowerPoint (PPT) presentations online in SlideServe. SlideServe has a very huge collection of Report coverage PowerPoint presentations. You can view or download Report coverage presentations for your school assignment or business presentation. Browse for the presentations on every topic that you want.